WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · HB 2528

Legislative bill overview

HB 2528 requires health benefit plans in Texas to cover prescription medications used to treat opioid and substance use disorders, including medications like methadone, buprenorphine, and naltrexone. The bill ensures these treatments are accessible without discriminatory coverage limitations compared to other medical conditions.

Why is this important

Medication-assisted treatment (MAT) is evidence-based care that significantly improves recovery outcomes and reduces overdose deaths, yet many insurance plans restrict or deny coverage for these drugs. This bill addresses a major barrier to treatment access during Texas's ongoing opioid crisis, potentially saving lives and reducing emergency room visits and incarceration rates.

Potential points of contention

  • Insurance cost concerns: Insurers may argue expanded mandatory coverage increases premiums and administrative burden, though evidence suggests MAT reduces overall healthcare costs
  • Definition and scope disputes: Disagreement over which specific medications and treatment protocols should be covered, and whether coverage extends to all plan types equally
  • Implementation challenges: Questions about how to enforce compliance, handle prior authorization requirements, and ensure equitable access across rural and urban areas

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.